ImmunoOncology research and a growing understanding of biomarkers is guiding advances in treatment for lungcancer patients. LCAM LCSM ScienceFromAtoZpic.twitter.comEFAiVg8eWZ

#ImmunoOncology research and a growing understanding of biomarkers is guiding advances in treatment for #lungcancer patients. #LCAM #LCSM #ScienceFromAtoZpic.twitter.com/EFAiVg8eWZ

09:42 EST 23 Nov 2018 | AztraZeneca

#ImmunoOncology research and a growing understanding of biomarkers is guiding advances in treatment for #lungcancer patients. #LCAM #LCSM #ScienceFromAtoZ pic.twitter.com/EFAiVg8eWZ

More From BioPortfolio on "#ImmunoOncology research and a growing understanding of biomarkers is guiding advances in treatment for #lungcancer patients. #LCAM #LCSM #ScienceFromAtoZpic.twitter.com/EFAiVg8eWZ"